2026 Joseph T. Coyle: Neuroscience Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Medicine	143	1490	1377	866	790	612	89225
Neuroscience	143	182	163	118	103	598	89088

Joseph T. Coyle publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Joseph T. Coyle sits on this spectrum.

38 publications 887+

This scientist: 598 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 887 publications or more.

Joseph T. Coyle D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Joseph T. Coyle sits on this spectrum.

30 D-Index 163+

This scientist: 143 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 163 D-Index or more.

Research.com Recognitions

2026 - Research.com Neuroscience in United States Leader Award
2025 - Research.com Neuroscience in United States Leader Award
2017 - Rhoda and Bernard Sarnat International Prize in Mental Health, National Academy of Medicine
2012 - Fellow, National Academy of Inventors
2004 - Fellow of the American Association for the Advancement of Science (AAAS)
1996 - Robert J. and Claire Pasarow Foundation Medical Research Award
1994 - Fellow of the American Academy of Arts and Sciences
1990 - Member of the National Academy of Medicine (NAM)

Overview

Joseph T. Coyle is affiliated with Harvard University in the United States. Their research spans several areas within neuroscience, biochemistry, genetics, and molecular biology, focusing particularly on cellular and molecular neuroscience, molecular biology, and biological psychiatry.

Their main research topics include:

Neuroscience and Neuropharmacology Research
Amino Acid Enzymes and Metabolism
Tryptophan and Brain Disorders
Epigenetics and DNA Methylation
Receptor Mechanisms and Signaling
Genetics and Neurodevelopmental Disorders
Neurotransmitter Receptor Influence on Behavior

Joseph T. Coyle has contributed several papers, with notable recent publications such as:

"Activated microglia cause metabolic disruptions in developmental cortical interneurons that persist in interneurons from individuals with schizophrenia," 2020, Nature Neuroscience
"Fifty Years of Research on Schizophrenia: The Ascendance of the Glutamatergic Synapse," 2020, American Journal of Psychiatry
"d-Serine, the Shape-Shifting NMDA Receptor Co-agonist," 2020, Neurochemical Research
"Postsynaptic Serine Racemase Regulates NMDA Receptor Function," 2020, Journal of Neuroscience
"Altered neural oscillations and behavior in a genetic mouse model of NMDA receptor hypofunction," 2021, Scientific Reports

Their frequent co-authors include Darrick T. Balu, Oluwarotimi Folorunso, Glenn Konopaske, Uwe Rudolph, and Ho-Jin Park.

Joseph T. Coyle's work has been published often in venues such as:

bioRxiv (Cold Spring Harbor Laboratory)
Neuropsychopharmacology
Proceedings of the National Academy of Sciences
Molecular Psychiatry
Nature Neuroscience

Over the course of their career, Joseph T. Coyle has received multiple recognitions, including:

Rhoda and Bernard Sarnat International Prize in Mental Health, National Academy of Medicine, 2017
Fellow, National Academy of Inventors, 2012
Fellow of the American Association for the Advancement of Science (AAAS), 2004
Robert J. and Claire Pasarow Foundation Medical Research Award, 1996
Fellow of the American Academy of Arts and Sciences, 1994
Member of the National Academy of Medicine (NAM), 1990

Best Publications

Oxidative stress, glutamate, and neurodegenerative disorders

Joseph T. Coyle;Pamela Puttfarcken

5014
Citations
Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain.

Peter J. Whitehouse;Donald L. Price;Robert G. Struble;Arthur W. Clark

4492
Citations
Alzheimer's disease: a disorder of cortical cholinergic innervation

Joseph T. Coyle;Donald L. Price;Mahlon R. DeLong

3882
Citations
Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis

Peter J. Whitehouse;Donald L. Price;Arthur W. Clark;Joseph T. Coyle

2251
Citations
Oxidative Stress in Neurodegenerative Diseases

N A Simonian;J T Coyle

1579
Citations
Lesion of striatal neurones with kainic acid provides a model for Huntington's chorea.

Joseph T. Coyle;Robert Schwarcz

1473
Citations
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia

John E. Lisman;Joseph T. Coyle;Robert W. Green;Daniel C. Javitt

1233
Citations
Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress

Timothy H. Murphy;Masaomi Miyamoto;Antonio Sastre;Ronald L. Schnaar

1224
Citations
The Emerging Role of Glutamate in the Pathophysiology and Treatment of Schizophrenia

Donald C. Goff;Joseph T. Coyle

1180
Citations
Neuropsychopharmacology : The Fifth Generation of Progress

Kenneth L. Davis;Dennis S. Charney;Joseph T. Coyle;Charles B. Nemeroff

1160
Citations
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis

Joseph T. Coyle

1135
Citations
Neurochemical aspects of the ontogenesis of gabanergic neurons in the rat brain

J.T. Coyle;S.J. Enna

1062
Citations
Catecholamines in fetal and newborn rat brain.

J. T. Coyle;D. Henry

1008
Citations
Neurobiology of schizophrenia.

Christopher A. Ross;Russell L. Margolis;Sarah A.J. Reading;Mikhail Pletnikov

918
Citations
Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis

Jeffrey D. Rothstein;Guochuan Tsai;Ralph W. Kuncl;Lora Clawson

850
Citations
D-serine added to antipsychotics for the treatment of schizophrenia

Guochuan Tsai;Pinchen Yang;Li-Chen Chung;Nicholas Lange

823
Citations
Review of the toxicology of chlorpyrifos with an emphasis on human exposure and neurodevelopment.

David L. Eaton;Robert B. Daroff;Herman Autrup;James Bridges

777
Citations
Glutamatergic Mechanisms in Schizophrenia

Guochuan Tsai;Joseph T. Coyle

764
Citations
Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies

M.L. Simmons;C.G. Frondoza;J.T. Coyle

745
Citations
In situ injection of kainic acid: A new method for selectively lesioning neuronal cell bodies while sparing axons of passage

Joseph T. Coyle;Mark E. Molliver;Michael J. Kuhar

698
Citations